Planet Ocean Underwater Hotels, LLC Establishes a Regulated Pathway to Safe Human Living Underwater Ready to Announce with Confidence?

Key West, Florida--(Newsfile Corp. - February 11, 2026) - Tony Webb, Managing Director of Planet Ocean Underwater Hotels, LLC, today announced that a documented, patent-protected pathway to safe human living underwater now exists, enabled by U.S. Patent Design D-736947 and advanced through the USA-UAE Coral Civilization Initiative. For the first time, underwater habitation is no longer experimental or permanent in nature. The Planet Ocean Underwater Hotel design establishes a movable, non-anchored, zero-discharge underwater living platform operating at shallow, human-safe depths, while remaining fully retrievable, relocatable, and storm-evasive.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

Click image above to view full announcement.

Planet Ocean Underwater Hotels, LLC is based in Key West, Florida with fabrication, assembly and training in Houma and Morgan City area.

Louisisana Employee-Owned operated endeavor that fabricates and operates affordable movable underwater luxury hotels for our global supporters.

Join the team in advancing humanity's first-time ever experiences towards living underwater - no greater than 30 feet. US Patent Design Underwater Hotel.

Contacts:

Tony Webb

1-321-266-4321

media@PlanetOceanUnderwaterHotel.com

Source: Planet Ocean Underwater Hotels, LLC

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283560

Source: Reportable, Inc.

Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Reportable, Inc. or all companies in the Multimedia / Internet / Online Services industry.

Stonegate Capital Partners Updates Coverage On Surf Air Mobility Inc. (SRFM) Q425

2026-03-13 4:37 PM EDT

Stonegate Capital Partners Updates Coverage on Aquafil Group (ECNL) Q425

2026-03-13 1:12 PM EDT

Glafabra Therapeutics Receives FDA Orphan Drug Designation for GT-GLA-S03, Advancing a Redosable Cell Therapy for Fabry Disease

2026-03-12 10:04 AM EDT

Jun 27, 2025

"Our company has issued news releases for over 25 years, often repeating our requirements with new providers. For the past six years,...

Multimedia / Internet / Online Services